Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
Clinical reports supporting an association between hemoglobin (Hb) levels, morbidity, and mortality were a strong part of the dataset used by the National Kidney Foundation in recommending a target Hb level of 11 to 12 g/dL in patients on dialysis. This article provides an overview of the potential link between Hb correction and improvements in morbidity and mortality in patients on dialysis.
Brattich
Mary
M
Fresenius Medical Care, San Diego, CA, USA.
D000740:Anemia / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D002423:Cause of Death; D006454:Hemoglobins / Q000378:metabolism*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000401:mortality / Q000628:therapy; D007902:Length of Stay / Q000706:statistics & numerical data; D009017:Morbidity; D017063:Outcome Assessment, Health Care; D006435:Renal Dialysis / Q000009:adverse effects* / Q000401:mortality; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors
D006454:Hemoglobins